These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 9724557)
21. Pharmacokinetic and safety evaluation of BILR 355, a second-generation nonnucleoside reverse transcriptase inhibitor, in healthy volunteers. Huang F; Koenen-Bergmann M; Macgregor TR; Ring A; Hattox S; Robinson P Antimicrob Agents Chemother; 2008 Dec; 52(12):4300-7. PubMed ID: 18824608 [TBL] [Abstract][Full Text] [Related]
22. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics. Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720 [TBL] [Abstract][Full Text] [Related]
23. Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent. Aneja R; Dhiman N; Idnani J; Awasthi A; Arora SK; Chandra R; Joshi HC Cancer Chemother Pharmacol; 2007 Nov; 60(6):831-9. PubMed ID: 17285314 [TBL] [Abstract][Full Text] [Related]
24. High performance liquid chromatographic analysis and preclinical pharmacokinetics of the heteroarotinoid antitumor agent, SHetA2. Zhang Y; Hua Y; Benbrook DM; Covey JM; Dai G; Liu Z; Chan KK Cancer Chemother Pharmacol; 2006 Nov; 58(5):561-9. PubMed ID: 16534614 [TBL] [Abstract][Full Text] [Related]
25. Highly suppressing wild-type HIV-1 and Y181C mutant HIV-1 strains by 10-chloromethyl-11-demethyl-12-oxo-calanolide A with druggable profile. Xue H; Lu X; Zheng P; Liu L; Han C; Hu J; Liu Z; Ma T; Li Y; Wang L; Chen Z; Liu G J Med Chem; 2010 Feb; 53(3):1397-401. PubMed ID: 20050672 [TBL] [Abstract][Full Text] [Related]
26. Inhibitors of HIV-1 attachment. Part 10. The discovery and structure-activity relationships of 4-azaindole cores. Wang T; Yang Z; Zhang Z; Gong YF; Riccardi KA; Lin PF; Parker DD; Rahematpura S; Mathew M; Zheng M; Meanwell NA; Kadow JF; Bender JA Bioorg Med Chem Lett; 2013 Jan; 23(1):213-7. PubMed ID: 23200254 [TBL] [Abstract][Full Text] [Related]
27. Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1. Egorin MJ; Zuhowski EG; Rosen DM; Sentz DL; Covey JM; Eiseman JL Cancer Chemother Pharmacol; 2001 Apr; 47(4):291-302. PubMed ID: 11345645 [TBL] [Abstract][Full Text] [Related]
28. Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent. Egorin MJ; Zuhowski EG; Sentz DL; Dobson JM; Callery PS; Eiseman JL Cancer Chemother Pharmacol; 1999; 44(4):283-94. PubMed ID: 10447575 [TBL] [Abstract][Full Text] [Related]
29. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
30. Metabolism and pharmacokinetics of the combination Zidovudine plus Lamivudine in the adult Erythrocebus patas monkey determined by liquid chromatography-tandem mass spectrometric analysis. Divi RL; Doerge DR; Twaddle NC; Shockley ME; St Claire MC; Harbaugh JW; Harbaugh SW; Poirier MC Toxicol Appl Pharmacol; 2008 Jan; 226(2):206-11. PubMed ID: 17949768 [TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 2nd communication: drops with ethanol. Lintz W; Barth H; Becker R; Frankus E; Schmidt-Böthelt E Arzneimittelforschung; 1998 May; 48(5):436-45. PubMed ID: 9638309 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the cassette dosing approach for assessing the pharmacokinetics of geldanamycin analogues in mice. Smith NF; Hayes A; Nutley BP; Raynaud FI; Workman P Cancer Chemother Pharmacol; 2004 Dec; 54(6):475-86. PubMed ID: 15526201 [TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories. Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614 [TBL] [Abstract][Full Text] [Related]
34. Preclinical pharmacology of ecteinascidin 729, a marine natural product with potent antitumor activity. Reid JM; Walker DL; Ames MM Cancer Chemother Pharmacol; 1996; 38(4):329-34. PubMed ID: 8674155 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs. Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus). Kim MS; Lim JH; Park BK; Hwang YH; Yun HI J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784 [TBL] [Abstract][Full Text] [Related]
37. In vivo anti-HIV activity of (+)-calanolide A in the hollow fiber mouse model. Xu ZQ; Hollingshead MG; Borgel S; Elder C; Khilevich A; Flavin MT Bioorg Med Chem Lett; 1999 Jan; 9(2):133-8. PubMed ID: 10021914 [TBL] [Abstract][Full Text] [Related]
38. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers. Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M Chirality; 1997; 9(3):297-302. PubMed ID: 9176996 [TBL] [Abstract][Full Text] [Related]
39. Chemical resolution of +/- -calanolide A, +/- -cordatolide A and their 11-demethyl analogues. Ma T; Gao Q; Chen Z; Wang L; Liu G Bioorg Med Chem Lett; 2008 Feb; 18(3):1079-83. PubMed ID: 18155519 [TBL] [Abstract][Full Text] [Related]
40. Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations. Göhler K; Brett M; Smit JW; Rengelshausen J; Terlinden R Int J Clin Pharmacol Ther; 2013 Apr; 51(4):338-48. PubMed ID: 23357834 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]